Innovita Biological Technology Co. Ltd. A (688253) — Capital Reinvestment Ratio
Innovita Biological Technology Co. Ltd. A (688253) has a Capital Reinvestment Ratio of 0.16x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥193.13 Million) in capital expenditures (CN¥31.13 Million). See Innovita Biological Technology Co. Ltd. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Innovita Biological Technology Co. Ltd. A Capital Reinvestment Ratio (2020–2025)
This chart tracks Innovita Biological Technology Co. Ltd. A's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Innovita Biological Technology Co. Ltd. A (2020–2025)
Year-by-year Capital Reinvestment Ratio for Innovita Biological Technology Co. Ltd. A from 2020 to 2025. For live market cap and broader valuation context, see 688253 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | CN¥193.13 Million | CN¥31.13 Million | ▲ +36.2% |
| 2024 | 0.12x | CN¥305.46 Million | CN¥36.16 Million | ▲ +81.3% |
| 2023 | 0.07x | CN¥259.85 Million | CN¥16.97 Million | ▼ -85.7% |
| 2022 | 0.46x | CN¥126.43 Million | CN¥57.71 Million | ▼ -23.9% |
| 2021 | 0.60x | CN¥106.27 Million | CN¥63.75 Million | ▲ +400.3% |
| 2020 | 0.12x | CN¥639.82 Million | CN¥76.71 Million | — |